These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4985285)

  • 21. Primary and acquired drug resistance in Mycobacterium tuberculosis strains in western region of Libyan Arab Jamahiriya.
    Elghoul MT; Joshi RM; Rizghalla T
    Trop Geogr Med; 1989 Oct; 41(4):304-8. PubMed ID: 2517554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug resistant tuberculosis in a large southern California hospital.
    Schiffman PL; Ashkar B; Bishop M; Cleary MG
    Am Rev Respir Dis; 1977 Nov; 116(5):821-5. PubMed ID: 411406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of ultraviolet irradiation on the acid-fastness of drug-resistant mutants of tubercle bacilli, with special reference to the virulence of isoniazid-resistant strains.
    Murohashi T; Yoshida K
    Am Rev Respir Dis; 1968 Feb; 97(2):283-91. PubMed ID: 4966163
    [No Abstract]   [Full Text] [Related]  

  • 24. The susceptibility of Mycobacterium tuberculosis to isoniazid and the Arg-->Leu mutation at codon 463 of katG are not associated.
    van Doorn HR; Kuijper EJ; van der Ende A; Welten AG; van Soolingen D; de Haas PE; Dankert J
    J Clin Microbiol; 2001 Apr; 39(4):1591-4. PubMed ID: 11283093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Decrease of isoniazid-resistant Mycobacterium strains].
    Fodor T
    Orv Hetil; 1979 Feb; 120(8):448. PubMed ID: 106354
    [No Abstract]   [Full Text] [Related]  

  • 26. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance.
    Musser JM; Kapur V; Williams DL; Kreiswirth BN; van Soolingen D; van Embden JD
    J Infect Dis; 1996 Jan; 173(1):196-202. PubMed ID: 8537659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic diversity of Mycobacterium tuberculosis isoniazid monoresistant and multidrug-resistant in Rio Grande do Sul, a tuberculosis high-burden state in Brazil.
    Esteves LS; Dalla Costa ER; Vasconcellos SEG; Vargas A; Ferreira Junior SLM; Halon ML; Ribeiro MO; Rodenbusch R; Gomes HM; Suffys PN; Rossetti MLR
    Tuberculosis (Edinb); 2018 May; 110():36-43. PubMed ID: 29779771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecular mechanisms of mycobacterium tuberculosis strains resistance to rifampicin and isoniazid].
    Stepanshina VN; Panfertsev EA; Mitrofanova GN; Korobova OV; Stepanshin IuG; Shemiakin IG; Medvedeva IM
    Probl Tuberk; 2000; (1):32-6. PubMed ID: 10750428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unveiling a tuberculosis drug target.
    Travis J
    Science; 1994 Jan; 263(5144):172. PubMed ID: 8284668
    [No Abstract]   [Full Text] [Related]  

  • 30. [Streptomycin and isoniazid resistance of strains of Mycobacterium tuberculosis isolated in Catania].
    Placenti A
    Lotta Tuberc; 1969; 39(4):264-74. PubMed ID: 4997375
    [No Abstract]   [Full Text] [Related]  

  • 31. [Niacin test and nicotinamide test in isoniazid resistant strains of Mycobacterium tuberculosis].
    Hergt R; Ogbuoto G; Nimmich W
    Z Tuberk Erkr Thoraxorg; 1968 Dec; 129(5):329-34. PubMed ID: 4239321
    [No Abstract]   [Full Text] [Related]  

  • 32. The trend of infection with drug-resistant strains of Mycobacterium tuberculosis among untreated patients. I. Isoniazid.
    Zaki MH; Lyons HA; Tizes R; Godinez F
    Am J Public Health Nations Health; 1969 Nov; 59(11):2056-66. PubMed ID: 4981880
    [No Abstract]   [Full Text] [Related]  

  • 33. [Significance of isoniazid for the therapy of experimental infection with total INH- and SM- resistant human tuberculosis bacteria in the mice].
    Matsumiya T; Freerksen E; Rosenfeld M
    Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):14-29. PubMed ID: 4320557
    [No Abstract]   [Full Text] [Related]  

  • 34. Selective effects of nitrofuraldoxime-anti on isoniazid resistant m. tuberculosis.
    Wayne LG; Russell RL
    Scand J Respir Dis; 1966; 47(1):18-26. PubMed ID: 4958046
    [No Abstract]   [Full Text] [Related]  

  • 35. [Studies on the development of drug-resistant tubercle bacilli in experimental animal tuberculosis].
    Yamanouchi T; Sawai A; Hori M
    Kekkaku; 1973 Jul; 48(7):277-95. PubMed ID: 4200057
    [No Abstract]   [Full Text] [Related]  

  • 36. The genotypic study of Mycobacterium tuberculosis complex resistant to isoniazid: Galicia, Spain (2008-2013).
    Pérez Del Molino ML; Barbeito-Castiñeiras G; Mejuto B; Alonso P; Fernández A; González-Mediero G;
    Eur J Clin Microbiol Infect Dis; 2016 Nov; 35(11):1795-1801. PubMed ID: 27586016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of in-vitro and in-vivo experiments with Mycobacterium tuberculosis in helping to plan chemotherapy regimens.
    Dickinson JM; Mitchison DA
    Tidsskr Nor Laegeforen; 1975 Jun; 95(17-18):1087-9. PubMed ID: 806991
    [No Abstract]   [Full Text] [Related]  

  • 38. Persistence, not resistance, is the cause of loss of isoniazid effect.
    Wallis RS; Palaci M; Eisenach K
    J Infect Dis; 2007 Jun; 195(12):1870-1; author reply 1872-3. PubMed ID: 17492604
    [No Abstract]   [Full Text] [Related]  

  • 39. Increasing drug resistance of Mycobacterium tuberculosis isolates in Ontario, Canada, 1987-1998.
    Remis RS; Jamieson F; Chedore P; Haddad A; Vernich L
    Clin Infect Dis; 2000 Aug; 31(2):427-32. PubMed ID: 10987700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of clinical significance for the common arginine-to-leucine substitution at codon 463 of the katG gene in isoniazid-resistant Mycobacterium tuberculosis in Singapore.
    Lee AS; Tang LL; Lim IH; Ling ML; Tay L; Wong SY
    J Infect Dis; 1997 Oct; 176(4):1125-7. PubMed ID: 9333184
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.